Hirakata, Japan

Kayoko Zushi

This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kayoko Zushi. Retrieved from https://idiyas.com/inventor/kayoko-zushi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kayoko Zushi: Innovator in Ischemic Brain Damage Treatment

Introduction

Kayoko Zushi is a prominent inventor based in Hirakata, Japan. She has made significant contributions to the field of medical science, particularly in the treatment of ischemic brain damage. Her innovative work has garnered attention and respect within the scientific community.

Latest Patents

Kayoko Zushi holds a patent for an agent designed to treat ischemic brain damage. This patent represents her commitment to advancing medical treatments and improving patient outcomes. She has 1 patent to her name, showcasing her dedication to innovation in healthcare.

Career Highlights

Zushi is affiliated with Dainippon Pharmaceutical Company, Limited, where she continues to work on groundbreaking research. Her role at the company allows her to collaborate with other experts in the field and contribute to the development of new therapies.

Collaborations

Throughout her career, Kayoko Zushi has worked alongside notable colleagues, including Yoshinobu Masuda and Mikio Kurokawa. These collaborations have enriched her research and expanded the impact of her inventions.

Conclusion

Kayoko Zushi is a trailblazer in the field of medical innovation, particularly in the treatment of ischemic brain damage. Her contributions through her patent and collaborations highlight her importance in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…